The local inflammatory environment of the cell promotes the growth of epithelial cancers. Therefore, controlling inflammation locally using a material in a sustained, non-steroidal fashion can effectively kill malignant cells without significant damage to surrounding healthy cells. A promising class of materials for such applications is the nanostructured scaffolds formed by epitope presenting minimalist self-assembled peptides; these are bioactive on a cellular length scale, while presenting as an easily handled hydrogel. Here, we show that the assembly process can distribute an anti-inflammatory polysaccharide, fucoidan, localized to the nanofibers within the scaffold to create a biomaterial for cancer therapy. We show that it supports healthy cells, while inducing apoptosis in cancerous epithelial cells, as demonstrated by the significant down-regulation of gene and protein expression pathways associated with epithelial cancer progression. Our findings highlight an innovative material approach with potential applications in local epithelial cancer immunotherapy and drug delivery.
Coassembled nanostructured bioscaffold reduces the expression of proinflammatory cytokines to induce apoptosis in epithelial cancer cells.
Rui Li,Sivapriya Pavuluri,K. Bruggeman,B. Long,A. Parnell,A. Martel,S. Parnell,F. Pfeffer,A. Dennison,K. Nicholas,C. Barrow,D. Nisbet,Richard J. Williams
Published 2016 in Nanomedicine : nanotechnology, biology, and medicine
ABSTRACT
PUBLICATION RECORD
- Publication year
2016
- Venue
Nanomedicine : nanotechnology, biology, and medicine
- Publication date
2016-07-01
- Fields of study
Medicine, Materials Science
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-65 of 65 references · Page 1 of 1
CITED BY
Showing 1-46 of 46 citing papers · Page 1 of 1